Who will watch the watchmen: unique challenges of T-cell redirecting therapies in T-cell malignancies

Jessica Elliott; David Ritchie; Rachel Koldej; Amit Khot

doi:10.1016/s2352-3026(26)00005-0

Related publications

Article2018

How to watch the watchmen? The role and measurement of regulatory governance

Rui Cunha Marques, Francisco Silva Pinto

Article2021

Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies

Carlos A. García‐Prieto, Lorea Villanueva, Alberto Bueno-Costa, Verónica Dávalos, Azucena González-Navarro, Manel Juan, Álvaro Urbano‐Ispizua, Julio Delgado, Valentín Ortiz‐Maldonado, Francesca Del Bufalo, Franco Locatelli, Concetta Quintarelli, Matilde Sinibaldi, Marta Soler, Manuel Castro de Moura, Gerardo Ferrer, Rocío G. Urdinguio, Agustín F. Fernández, Mario F. Fraga, Diana Bar, Amilia Meir, Orit Itzhaki, Michal J. Besser, Abraham Avigdor, Elad Jacoby, Manel Esteller

Article2018

The critical role of tumour-resident cytotoxic T cells in human malignancies

Jarem Edwards, James S. Wilmott, Jason Madore, Rehana Hewavisenti, Angela L. Ferguson, Warwick J. Britton, Alexander M. Menzies, Angela Hong, Georgina V. Long, Richard A Scolyer, Mainthan Palendira

Article2002

Redundant and Unique Roles of Two Enhancer Elements in the TCRγ Locus in Gene Regulation and γδ T Cell Development

Na Xiong, Chulho Kang, David H Raulet

Article2020

The potential and challenges of patient-derived organoids in guiding the multimodality treatment of upper gastrointestinal malignancies

Georg Busslinger, Fianne Lissendorp, Ingrid A. Franken, Richard van Hillegersberg, Jelle P. Ruurda, Hans Clevers, Michiel F.G. de Maat